✦ LIBER ✦

Prospective Open Label Study of Solifenacin for Overactive Bladder in Children

✍ Scribed by Bolduc, Stéphane; Moore, Katherine; Nadeau, Geneviève; Lebel, Sylvie; Lamontagne, Pascale; Hamel, Micheline

Book ID: 123352410
Publisher: Lippincott Williams and Wilkins
Year: 2010
Tongue: English
Weight: 197 KB
Volume: 184
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2010.03.124

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

SOLIFENACIN IN MULTIPLE SCLEROSIS PATIEN

SOLIFENACIN IN MULTIPLE SCLEROSIS PATIENTS WITH OVERACTIVE BLADDER – A PROSPECTIVE STUDY

✍ Van Rey, F.; Heesakkers, J. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Efficacy and safety of solifenacin to tr

Efficacy and safety of solifenacin to treat overactive bladder symptoms in patients with idiopathic normal pressure hydrocephalus: An open-label, multicenter, prospective study

✍ Jae Hoon Chung; Joo Yong Lee; Dong Hyuk Kang; U-Syn Ha; Seung Hwan Lee; Won Sik 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

MP75-03 A PROSPECTIVE RANDOMIZED OPEN-LA

MP75-03 A PROSPECTIVE RANDOMIZED OPEN-LABEL CLINICAL OBSERVATIONAL STUDY TO ASSESS THE EFFECTIVENESS OF ADDING TAMSULOSIN IN WOMEN TREATED WITH SOLIFENACIN FOR OVERACTIVE BLADDER

✍ Yoo, Changhee; Kim, Sun Il; Bae, Jae Hyun; Son, Jung Hwan; Oh, Cheol Young; Yoon 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 222 KB

Long-Term Open-Label Solifenacin Treatme

Long-Term Open-Label Solifenacin Treatment Associated with Persistence with Therapy in Patients with Overactive Bladder Syndrome

✍ F. Haab; L. Cardozo; C. Chapple; A.M. Ridder 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 244 KB

234Rapid onset of therapeutic efficacy f

234Rapid onset of therapeutic efficacy for tolterodine in patients with overactive bladder: Secondary analysis of a prospective open-label study

✍ D. Sussman; M. Carlsson 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 178 KB

Solifenacin treatment for overactive bla

Solifenacin treatment for overactive bladder in Hispanic patients: patient-reported symptom bother and quality of life outcomes from the VESIcare® Open-Label Trial

✍ J. P. Capo’ Jr; C. Laramée; V. Lucente; A. Fakhoury; S. Forero-Schwanhaeuser 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB